Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers

Pediatric Infectious Disease Journal

Volumn 32, Issue 5, 2013, Pages 543-548

  Kudinha, Timothy ^a,c   Johnson, James R ^b   Andrew, Scott D ^a   Kong, Fanrong ^c   Anderson, Peter ^a   Gilbert, Gwendolyn L ^c,d  

^a CHARLES STURT UNIVERSITY   (Australia)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clonal; Escherichia coli; Phylogenetic; Virulence factors

Indexed keywords

CELLULOSE; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; CHILD; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYELONEPHRITIS;

EID: 85027935207     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828ba3f1     Document Type: Article

References (41)

1. Chakupurakal R, Ahmed M, Sobithadevi DN, et al. Urinary tract pathogens and resistance pattern. J Clin Pathol. 2010;63:652-654.
2. Draghijeva E. Virulence factors in Escherichia coli from children with pyelonephritis. CMI 1999;6:328-333.
3. Shaikh N, Morone NE, Bost JE, et al. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008;27:302-308.
4. Israele V, Darabi A, McCracken GH Jr. The role of bacterial virulence factors and Tamm-Horsfall protein in the pathogenesis of Escherichia coli urinary tract infection in infants. Am J Dis Child. 1987;141:1230-1234.
5. Kanawal K, Makker S. Clinical Pediatric Nephrology. New York: McGrew-Hill;1994.
6. Leroy S, Chalumeau T, Ulinski T, et al. Impressive renal damage after acute pyelonephritis in a child. Pediatr Nephrol. 2010;25:1365-1368.
7. Catal F, Bavbek N, Bayrak O, et al. Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006. Int Urol Nephrol. 2009;41:953-957.
8. Kai-Larsen Y, Lüthje P, Chromek M, et al. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 2010;6:e1001010.
9. Lüthje P, Brauner A. Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract. J Clin Microbiol. 2010;48:2316-2317.
10. Craig JC, Simpson JM, Williams GJ, et al.; Prevention of Recurrent Urinary Tract Infection in Children with Vesicoureteric Reflux and Normal Renal Tracts (PRIVENT) Investigators. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009;361:1748-1759.
11. Siegfried L, Kmetova M, Puzová H, et al. Virulence-associated factors in Escherichia coli strains isolated from children with urinary tract infections. J Med Microbiol. 1994;41:127-132.
12. Clermont O, Dhanji H, Upton M, et al. Rapid detection of the 025b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother. 2009;64:274-277.
13. Johnson JR, Menard M, Johnston B, et al. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother. 2009;53: 2733-2739.
14. Platell JL, Cobbold RN, Johnson JR, et al. Commonality among fluoroqui-nolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother. 2011;55:3782-3787.
15. Soto SM, Smithson A, Martinez JA, et al. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol. 2007;177:365-368.
16. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991;4:80-128.
17. Johnson JR, Owens K, Gajewski A, et al. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol. 2005;43: 6064-6072.
18. Kudinha T, Kong F, Johnson JR, et al. Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli. Appl Environ Microbiol. 2012;78:1198-1202.
19. Johnson JR, Clermont O, Menard M, et al. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis. 2006;194:1141-1150.
20. Picard B, Sevali-Garcia J, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun. 1999;67:546-553.
21. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555-4558.
22. Clermont O, Johnson JR, Menard M, et al. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis. 2007;57:129-136.
23. Andreu A, Stapleton AE, Fennell C, et al. Urovirulence determinants in Escherichia coli strains causing prostatitis. J Infect Dis. 1997;176:464-469.
24. Römling U Characterization of the rdar morphotype, a multicellular behaviour in Enterobacteriaceae. Cell Mol Life Sci. 2005;62:1234-1246.
25. Hancock V, Ferneres L, Klemm P The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli inhuman urine. Microbiology (Reading, Engl). 2008;154(Pt 1):167-175.
26. Johnson JR, Anderson JT, Clabots C, et al. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J. 2010;29:473-475.
27. Woods KL, Johnson JR, Padkowsky S, et al. Community-associated Escherichia coli harboring CTX-M B-lactamases from urine cultures from pediatric patients. Antimicrob Agents Chemother. 2012;56:2209-2210.
28. Leflon-Guibout V, Jurand C, Bonacorsi S, et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother. 2004;48:3736-3742.
29. Kudinha T, Johnson JR, Andrew SD, et al. Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clin Microbiol Infect. 2013;19:E173-E180.
30. Moreno E, Johnson JR, Pérez T, et al. Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect. 2009; 11:274-280.
31. Sannes MR, Kuskowski MA, Owens K, et al. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis. 2004;190:2121-2128.
32. Zhang L, Foxman B, Marrs C. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol. 2002;40:3951-3955.
33. Johanson IM, Plos K, Marklund BI, et al. Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb Pathog. 1993;15:121-129.
34. Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin N Am. 2003;17:261-278.
35. Johnson JR, Kuskowski M. Clonal origin, virulence factors, and virulence. Infect Immun. 2000;68:424-425.
36. Johnson JR, Kuskowski MA, Gajewski A, et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis. 2005;191:46-50.
37. Johnson JR, Russo TA, Brown JJ, et al. papG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. J Infect Dis. 1998;177:97-101.
38. Otto G, Sandberg T, Marklund BI, et al. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin Infect Dis. 1993;17:448-456.
39. Foxman B, Zhang L, Tallman P, et al. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J InfectDis. 1995;172:1536-1541.
40. Foxman B, Zhang L, Palin K, et al. Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. J Infect Dis. 1995;171:1514-1521.
41. Lundrigan MD, Webb RM. Prevalence of ompT among Escherichia coli isolates of human origin. FEMS Microbiol Lett. 1992;76:51-56.